CommercialCoverageMedium impact
Remote Electrical Neuromodulation for Migraines
Blue Cross & Blue Shield of Mississippi·MS · Neurology, Family Medicine, Internal Medicine +1 more·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS Mississippi has established new coverage criteria for Remote Electrical Neuromodulation devices (Nerivio) for migraine prevention and treatment. The policy covers both acute and preventive use with specific requirements including age restrictions (18+ for preventive care), headache frequency criteria (6-24 headache days per month), and requirements for failed conventional treatments or special circumstances.
Action Required
Immediately: Review current migraine patients using or requesting Nerivio devices. Ensure documentation meets new criteria: age 18+ for preventive use, 6-24 headache days per month for 3 months, and evidence of insufficient response to 2+ guideline-recommended preventive medications OR pregnancy/breastfeeding OR medication overuse risk OR drug interaction concerns. Update prior authorization requests to include ICHD-3 diagnostic criteria documentation and compliance/clinical benefit records for continued use.